Effects of Denosumab on Bone Metabolic Markers and Bone Mineral Density in Patients Treated with Glucocorticoids

Objective We performed a prospective study to determine the efficacy and safety of denosumab on bone metabolic indices and bone mineral density (BMD) in 29 patients receiving long-term glucocorticoids (GCs) who had clinical risk factors for fracture. Methods Among these patients, 16 had systemic lup...

Descripción completa

Detalles Bibliográficos
Autores principales: Sawamura, Masato, Komatsuda, Atsushi, Togashi, Masaru, Wakui, Hideki, Takahashi, Naoto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410471/
https://www.ncbi.nlm.nih.gov/pubmed/28321061

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5410471/
https://www.ncbi.nlm.nih.gov/pubmed/28321061

Ejemplares similares